SH3PXD2A and colorectal carcinoma: These results highlighted a critical role for SH3PXD2A-AS1 in regulating CRC growth and metastasis through the p53 signaling pathway and suggested that SH3PXD2A-AS1 may serve as a clinical diagnostic and prognostic biomarker and as a potential therapeutic target in CRC.